Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Saudi rEgistry of Cardiovascular Risk factor managEmenT in HemoDialysis patients	Sanofi	Ongoing	N/A	4	2	King Abdulaziz University Hospital (Jeddah), King Fahad Hospital (Jeddah), King Khalid General Hospital (Hail), King Abdulaziz University Hospital (Jeddah), Al-Noor Specialist Hospital (Makkah), Dr. Soliman Fakeeh Hospital (Jeddah), King Salman Kidney Diseases Center (Riyadh)
Multinational, Prospective, Observational Study to Assess the Unmet Medical Needs associated with Basal Insulin Use in Patients with Type 2 Diabetes Newly or Recently Initiated with Basal Insulin Treatment	Sanofi	Ongoing	N/A	4	OBS13780	King Khalid University Hospital (Riyadh)
A multicenter, observational, prospective study of the use of Diclofenac Sodium 75 mg Dual Release Capsules (Divido®) on adult patients with persistent or chronic pain and inflammation in Saudi Arabia	Tabuk Pharmaceuticals	Ongoing	Divido	4	D-001	King Fahad Medical City (Riyadh)
Verifying Insulin Strategy and Initial Health Outcome Analysi	Eli Lilly	Ongoing	N/A	4	F3Z-MC-B01	International Medical Center (Jeddah), King Fahd University Hospital (al khobar), King Fahad Medical (City), Armed Forces Hospital (Taif)
Evaluation of Asthma Management in Middle EAst North Africa Adult population ( ESMAA Study )	AstraZeneca	Ongoing	N/A	4	RME-XXX-20	Soliman Fakeeh Hospital (Jeddah), King Abdulaziz Hospital and Oncology Center (Jeddah), Armed Forces Hospital (dhahran), King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Armed Forces Hospital (Taif), King Fahad Specialist Hospital (Dammam), International Medical Center (Jeddah), King Abdulaziz University Hospital (Jeddah), King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Faisal Specialist Hospital and Research Center (Jeddah)
(LUMINOUS)Study to observe the effectiveness andsafety of ranibizumab through individualized patienttreatment and associated	Novartis	Ongoing	Ranibizumab 10mg/ml (Lucentis)	4	FB002A2406	King Abdulaziz Medical City NG (Riyadh), King Abdulaziz Medical City NG (Jeddah) , Prince Sultan Military Medical City (Riyadh)
The Effect of Vitamin D3 on Biomarkers of Glycaemia and Oxidative Stress in Saudi Men with Poorly-Controlled Type 2 Diabetes Mellitus	King Fahad Medical City	Ongoing	Vitamin D Capsules	4	H-01-R-012	King Fahad Medical City (Riyadh)
Dyslipidemia International Study II: Lipid target achievement in high risk patients with Acute Coronary Syndrome (DYSIS II)	MSD	Ongoing	N/A	4	0653A 427	Riyadh Care Hospital  (Riyadh), Dr. Soliman Fakeeh Hospital (Jeddah), King Faisal Specialist Hospital and Research Center (Riyadh)
Use Of High Dose Colistin in Multi Drug Resistant Gram Negative Infections in Critically Ill Adult Patients. Randomized Controlled Clinical Trial	King Saud Medical City	Ongoing	Colistin	4	CCD-AFM-00	King Saud Medical City (Riyadh)
A multicenter, observational, prospective Study of theuse of Valsartan (Tabuvan®) and Valsartan HCTZ (co-Tabuvan®) on adult patients with essentialHypertension in Saudi Arabia	Tabuk Pharmaceuticals	Ongoing	Tabuvan	4	T-VAHST	Prince Sultan Military Medical City (Riyadh)